⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15887093 | 1.00 | — | — | |
| SCHEMBL2109310 | 1.00 | — | — | |
| SCHEMBL15887094 | 1.00 | — | — | |
| SCHEMBL19371148 | 1.00 | — | — | |
| SCHEMBL20200287 | 1.00 | — | — | |
| SCHEMBL24831717 | 1.00 | — | — | |
| SCHEMBL20276680 | 0.82 | CCR5 (0.32) | — | |
| SCHEMBL1427994 | 0.78 | — | — | |
| SCHEMBL89457 | 0.78 | — | — | |
| SCHEMBL5381064 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240308961-A1 | Purification Method For 3-Amino-5-Methylpiperidine With Amino Protected By Boc | ZHEJIANG CHANGHAI PHARMACEUTICALS CO., LTD. (CN) | 2024-09-19 | — | — | US | claimed |
| CN-116332831-A | Purification method of 3-amino-5-methylpiperidine with amino protected by Boc | 浙江医药股份有限公司新昌制药厂 | 2023-06-27 | — | — | CN | claimed |
| US-9090593-B2 | Bicyclic compounds as Pim inhibitors | AMGEN INC. (US) | 2015-07-28 | — | — | US | claimed |
| EP-2702063-A1 | BICYCLIC PYRIDAZINE COMPOUNDS AS PIM INHIBITORS | Amgen Inc. (US) | 2014-03-05 | — | — | EP | claimed |
| US-20140031360-A1 | BICYCLIC COMPOUNDS AS PIM INHIBITORS | AMGEN INC. (US) | 2014-01-30 | — | — | US | claimed |
| EP-2649065-A1 | BICYCLIC COMPOUNDS AS PIM INHIBITORS | Amgen Inc. (US) | 2013-10-16 | — | — | EP | claimed |
| WO-2012148775-A1 | BICYCLIC PYRIDAZINE COMPOUNDS AS PIM INHIBITORS | AMGEN INC. (US) | 2012-11-01 | — | — | WO | claimed |
| WO-2012078777-A1 | BICYCLIC COMPOUNDS AS PIM INHIBITORS | AMGEN INC. (US) | 2012-06-14 | — | — | WO | claimed |
| CN-116332831-B | Purification method of 3-amino-5-methylpiperidine with amino protected by Boc | 浙江医药股份有限公司新昌制药厂 | 2025-10-28 | — | — | CN | disclosed |
| CN-116332831-B | Purification method of 3-amino-5-methylpiperidine with amino protected by Boc | 浙江医药股份有限公司新昌制药厂 | 2025-10-28 | — | — | CN | disclosed |
| US-20240308961-A1 | Purification Method For 3-Amino-5-Methylpiperidine With Amino Protected By Boc | ZHEJIANG CHANGHAI PHARMACEUTICALS CO., LTD. (CN) | 2024-09-19 | — | — | US | disclosed |
| US-20240308961-A1 | Purification Method For 3-Amino-5-Methylpiperidine With Amino Protected By Boc | ZHEJIANG CHANGHAI PHARMACEUTICALS CO., LTD. (CN) | 2024-09-19 | — | — | US | disclosed |
| US-20240308961-A1 | Purification Method For 3-Amino-5-Methylpiperidine With Amino Protected By Boc | ZHEJIANG CHANGHAI PHARMACEUTICALS CO., LTD. (CN) | 2024-09-19 | — | — | US | disclosed |
| CN-116332831-A | Purification method of 3-amino-5-methylpiperidine with amino protected by Boc | 浙江医药股份有限公司新昌制药厂 | 2023-06-27 | — | — | CN | disclosed |
| EP-2796456-A1 | Bicyclic compounds as Pim inhibitors | Amgen Inc. (US) | 2014-10-29 | — | — | EP | disclosed |
| EP-2702063-A1 | BICYCLIC PYRIDAZINE COMPOUNDS AS PIM INHIBITORS | Amgen Inc. (US) | 2014-03-05 | — | — | EP | disclosed |
| US-20140031360-A1 | BICYCLIC COMPOUNDS AS PIM INHIBITORS | AMGEN INC. (US) | 2014-01-30 | — | — | US | disclosed |
| EP-2649065-A1 | BICYCLIC COMPOUNDS AS PIM INHIBITORS | Amgen Inc. (US) | 2013-10-16 | — | — | EP | disclosed |
| WO-2012148775-A1 | BICYCLIC PYRIDAZINE COMPOUNDS AS PIM INHIBITORS | AMGEN INC. (US) | 2012-11-01 | — | — | WO | disclosed |
| WO-2012078777-A1 | BICYCLIC COMPOUNDS AS PIM INHIBITORS | AMGEN INC. (US) | 2012-06-14 | — | — | WO | disclosed |